Clinical actionability and therapy selection for advanced NSCLC patients tested using comprehensive genomic profiling

B. Bapat; R. Weerasinghe; R. Meng; A. Dowdell; S. C. Chang; B. Schroeder; C. Bifulco; B. Piening

doi:10.1016/S0959-8049(22)01057-7

Clinical actionability and therapy selection for advanced NSCLC patients tested using comprehensive genomic profiling

B. Bapat, R. Weerasinghe, R. Meng, A. Dowdell, S. C. Chang, B. Schroeder, C. Bifulco, B. Piening

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S97-S98
Journal	European Journal of Cancer
Volume	174
DOIs	https://doi.org/10.1016/S0959-8049(22)01057-7
State	Published - Oct 2022

Access to Document

10.1016/S0959-8049(22)01057-7

Cite this

@article{fc8a7d8bb5414b0a9859d3d678d859a3,

title = "Clinical actionability and therapy selection for advanced NSCLC patients tested using comprehensive genomic profiling",

author = "B. Bapat and R. Weerasinghe and R. Meng and A. Dowdell and Chang, {S. C.} and B. Schroeder and C. Bifulco and B. Piening",

note = "Funding Information: Corporate-sponsored Research: Brian Piening is recipient of a research grant from Illumina Inc.",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)01057-7",

language = "English",

volume = "174",

pages = "S97--S98",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - Clinical actionability and therapy selection for advanced NSCLC patients tested using comprehensive genomic profiling

AU - Bapat, B.

AU - Weerasinghe, R.

AU - Meng, R.

AU - Dowdell, A.

AU - Chang, S. C.

AU - Schroeder, B.

AU - Bifulco, C.

AU - Piening, B.

N1 - Funding Information: Corporate-sponsored Research: Brian Piening is recipient of a research grant from Illumina Inc.

PY - 2022/10

Y1 - 2022/10

UR - http://www.scopus.com/inward/record.url?scp=85140474524&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(22)01057-7

DO - 10.1016/S0959-8049(22)01057-7

M3 - Article

AN - SCOPUS:85140474524

SN - 0959-8049

VL - 174

SP - S97-S98

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Clinical actionability and therapy selection for advanced NSCLC patients tested using comprehensive genomic profiling

Access to Document

Other files and links

Cite this